An Exploration of Fetish Social Networks and Communities

Online Social Networks (OSNs) provide a venue for virtual interactions and relationships between individuals. In some communities, OSNs also facilitate arranging offline meetings and relationships. FetLife, the world’s largest anonymous social network for the BDSM, fetish and kink communities, provides a unique example of an OSN that serves as an interaction space, community organizing tool, and sexual market. In this paper, we present a first look at the characteristics of European members of Fetlife, comprising 504,416 individual nodes with 1,912,196 connections. We looked at user characteristics in terms of gender, sexual orientation, and preferred role. We further examined the homophilic communities and find that women in particular are far more platonically involved on the site than straight males. Our results suggest there are important differences between the FetLife community and conventional OSNs

Transient mTOR Inhibition Facilitates Continuous Growth of Liver Tumors by Modulating the Maintenance of CD133+ Cell Populations

The mammalian target of the rapamycin (mTOR) pathway, which drives cell proliferation, is frequently hyperactivated in a variety of malignancies. Therefore, the inhibition of the mTOR pathway has been considered as an appropriate approach for cancer therapy. In this study, we examined the roles of mTOR in the maintenance and differentiation of cancer stem-like cells (CSCs), the conversion of conventional cancer cells to CSCs and continuous tumor growth in vivo. In H-Ras-transformed mouse liver tumor cells, we found that pharmacological inhibition of mTOR with rapamycin greatly increased not only the CD133+ populations both in vitro and in vivo but also the expression of stem cell-like genes. Enhancing mTOR activity by over-expressing Rheb significantly decreased CD133 expression, whereas knockdown of the mTOR yielded an opposite effect. In addition, mTOR inhibition severely blocked the differentiation of CD133+ to CD133- liver tumor cells. Strikingly, single-cell culture experiments revealed that CD133- liver tumor cells were capable of converting to CD133+ cells and the inhibition of mTOR signaling substantially promoted this conversion. In serial implantation of tumor xenografts in nude BALB/c mice, the residual tumor cells that were exposed to rapamycin in vivo displayed higher CD133 expression and had increased secondary tumorigenicity compared with the control group. Moreover, rapamycin treatment also enhanced the level of stem cell-associated genes and CD133 expression in certain human liver tumor cell lines, such as Huh7, PLC/PRC/7 and Hep3B. The mTOR pathway is significantly involved in the generation and the differentiation of tumorigenic liver CSCs. These results may be valuable for the design of more rational strategies to control clinical malignant HCC using mTOR inhibitors

Rationally mispriced assets in equilibrium

Asymmetric information, Rational expectations, Mispricing, Efficiency, D43, D51, D8,